hypertrophic scar


Also found in: Dictionary, Thesaurus, Legal, Acronyms, Encyclopedia.

hy·per·tro·phic scar

an elevated scar resembling a keloid but which does not spread into surrounding tissues, is rarely painful, and regresses spontaneously; collagen bundles run parallel to the skin surface.

hypertrophic scar

Keloid, see there.

hypertrophic scar

A keloidal scar that develops with excessive or exuberant fibrous tissue, is easily visible, is raised above the surrounding skin, and sometimes causes contracture.

hypertrophic

characterized by a state of hypertrophy.

hypertrophic pulmonary osteoarthropathy
see hypertrophic osteopathy.
hypertrophic scar
a protruding scar resembling a fibroma or collagen nevus.

scar

cicatrix; a mark remaining after the healing of a wound, such as one caused by injury, illness or surgery.

constricting scar
contraction of scar tissue causing constriction of vascular channel or hollow viscus.
honorable scar
in judging dogs, scars resulting from injuries suffered as a result of work are permissible and do not detract from the dog's features.
hypertrophic scar
an overabundance of connective tissue in a wound, identified by history of traumatized wound, infection and histological examination reveals hairs, foreign body, pockets of infection.
scar tissue
a dense mass of granulation tissue.
References in periodicals archive ?
Effect of asiaticoside on the expression of transforming growth factor-beta mRNA and matrix metalloproteinases in hypertrophic scars.
Asilian A, Darougheh A, Shariati E New combination of triamcinolone, 5-fluorouracil, and pulsed-dye laser for treatment of keloid and hypertrophic scars.
Current revision surgery for hypertrophic scars is significantly limited, as many such scars recur post-surgery," said Dr.
Topical silicone gel sheeting has been used for more than 20 years to help reduce the size of hypertrophic scars and keloids.
RXi Pharmaceuticals Corporation (OTC: RXII), today announced that dosing with their anti-scarring drug, RXI-109, for the management of surgical and hypertrophic scars and keloids has been initiated.
Scar formation after cutaneous trauma, surgical or otherwise, encompasses a broad spectrum, ranging from normal scars to hypertrophic scars to keloids.
has announced that the first patient was treated in a Phase I physician-sponsored trial using its investigational new drug, code named, VIT100, to treat keloids and hypertrophic scars.
This drug candidate is a highly selective CTGF targeting sd-rxRNA[R] compound that is administered through intradermal injections toprevent or reduce dermal scarring following surgery or trauma, as well as for the management of hypertrophic scars and keloids.
Currently, there are three ongoing Phase 2a trials evaluating the effect of RXI-109 on scar formation in the skin after surgical revision of hypertrophic scars or keloids.
Outcomes are different, as well; keloids tend to grow and recur, while hypertrophic scars often regress with time.